Other Industry Events

The NYSCF Conference is the leading scientific meeting on translational stem cell research. It annually convenes over 500 participants from academia, industry, government, non-profits, and patient groups. Speakers include world-renowned, multi-disciplinary scientists, who will present their latest findings about the transformative impact of stem cell research on numerous diseases with a high unmet need.

For more information and to register please visit: https://nyscf.org/events/conference/

Confirmed Speakers, Panelists, and Chairs:

• Derrick Rossi, PhD — Founder, Moderna Therapeutics
• Tony Coles, MD — Cerevel Therapeutics
• Michelle McMurry-Heath, MD, PhD — Biotechnology Innovation Organization
• Domenico Accili, MD — Columbia University Medical Center
• Laura Andres-Martin, PhD — The NYSCF Research Institute
• Paola Arlotta, PhD – Harvard University
• Marie Bernard, MD — National Institutes of Health
• Shuibing Chen, PhD – Weill Cornell Medicine
• Alice Chen-Plotkin, MD – University of Pennsylvania
• Jose Conejo-Garcia, MD, PhD – Moffitt Cancer Center
• Tobias Deuse, MD — University of California, San Francisco
• Jennifer Elisseeff, PhD – Johns Hopkins University
• Valentina Fossati, PhD – The NYSCF Research Institute
• Valentina Greco, PhD – Yale University
• Ya-Chieh Hsu, PhD – Harvard University
• Shane Liddelow, PhD – NYU Langone Health
• Alysson Muotri, PhD – University of California, San Diego
• Shahin Rafii, MD – Weill Cornell Medicine
• Carolyn Rodriguez, MD, PhD — Stanford University
• Lee Rubin, PhD – Harvard Stem Cell Institute
• Krishanu Saha, PhD – University of Wisconsin-Madison
• Sohrab Shah, PhD – Memorial Sloan Kettering Cancer Center
• Padmanee Sharma, MD, PhD — MD Anderson Cancer Center
• Susan L. Solomon, JD – The NYSCF Research Institute
• Viviane Tabar, MD – Memorial Sloan Kettering Cancer Center
• Takanori Takebe, MD, PhD – Cincinnati Children’s Hospital Medical Center
• Craig B. Thompson, MD – Memorial Sloan Kettering Cancer Center
• Matthias von Herrath, MD – La Jolla Institute for Immunology; NovoNordisk
• Celia Witten, MD, PhD – Food and Drug Administration
• Rachel Yehuda, PhD – Icahn School of Medicine at Mount Sinai